DIAMINE DERIVATIVE, PRODUCTION PROCESS, AND ANTIOXIDIZING DRUG

(19)

(11)

EP 1 614 684 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.08.2009 Bulletin 2009/32

(45)	Mention of the grant of the patent:
	18.02.2009 Bulletin 2009/08

(21)	Application number: 04727146.5

(22)	Date of filing: 13.04.2004

(51)

International Patent Classification (IPC):

C07D 307/79^(2006.01)
A61K 31/343^(2006.01)
A61P 1/04^(2006.01)
A61P 9/00^(2006.01)
A61P 13/12^(2006.01)
A61P 25/28^(2006.01)

C07D 311/70^(2006.01)
A61K 31/353^(2006.01)
A61P 3/10^(2006.01)
A61P 9/10^(2006.01)
A61P 17/02^(2006.01)

(86)	International application number:
	PCT/JP2004/005240

(87)	International publication number:
	WO 2004/092153 (28.10.2004 Gazette 2004/44)

(54)	DIAMINE DERIVATIVE, PRODUCTION PROCESS, AND ANTIOXIDIZING DRUG DIAMINDERIVAT, HERSTELLUNGSVERFAHREN UND ANTIOXIDATIONS-ARZNEIMITTEL DERIVE DIAMINE, PROCEDE DE PRODUCTION ET MEDICAMENT ANTIOXYDANT

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

14.04.2003 JP 2003109665
30.01.2004 JP 2004022719

(43)	Date of publication of application:
	11.01.2006 Bulletin 2006/02

(73)	Proprietor: NIPPON SODA CO., LTD.
	Chiyoda-ku, Tokyo 100-8165 (JP)

(72)	Inventors:
	UMEDA, Nobuhiro, c/o Odawara Research Center Odawara-shi, Kanagawa 250-0280 (JP) MOCHIZUKI, Nobuo, c/o Odawara Research Center Odawara-shi, Kanagawa 250-0280 (JP) UCHIDA, Seiichi, c/o Odawra Research Center Odawara-shi, Kanagawa 250-0280 (JP) IKEYAMA, Seiichi, c/o Odawara Research Center Odawara-shi, Kanagawa 250-0280 (JP)

(74)	Representative: Wibbelmann, Jobst
	Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstrasse 2 81541 München 81541 München (DE)

(56)

References cited: :

JP-A- 02 288 856
JP-A- 05 310 724

JP-A- 05 140 142
JP-A- 08 503 922

OHKAWA S. ET AL: '5-Aminocoumarans: Dual Inhibitors of Lipid Peroxidation and Dopamine Release with Protective Effects against Central Nervous System Trauma and Ischemia' JOURNAL OF MEDICINAL CHEMISTRY vol. 40, no. 4, 1997, pages 559 - 573, XP002979756

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).